On 10 February 2019, the popular vote in the canton of Basel-City has resulted in an important success for the Basel-City political parties, the Basel-City administration and the economic region. The “compromise for the implementation of Tax Proposal 17”, has been accepted by a large majority. Authors: Andrea Bätscher and Dominik Bürgy.
The Swiss VAT Ordinance as well as VAT Leaflet No. 18 “Refund Procedure” have been updated as per 1 January 2019. The rules as announced on 17 September 2018 in the draft brochure with respect to refund of input VAT incurred prior to a mandatory VAT registration for foreign persons have fully been implemented. Authors: Silke … More Update – limited input VAT refund period for VAT payers domiciled abroad!
Life sciences companies must consider how to participate in emerging care platforms. Jürg Zürcher, Biotech/Medtech Leader at EY Switzerland, Germany and Austria, answers three questions. What does EY mean by the term Life Sciences 4.0? Increased customer expectations and rapid technological advances are disrupting the healthcare industry, causing power to shift across traditional stakeholder groups … More Life Sciences 4.0 – the next step in evolution?
In our series regarding the Swiss Federal Council report of 14 December 2018 DLT-technologies and Blockchain, our EY-specialists provide you with an overview of the applicability of the current Swiss financial market law on your FinTech-, DLT-, Blockchain-, DAO- business as well as your tokens. Authors: Darko Stefanoski, Orkan Sahin, Loric Szalai
The European Securities and Markets Authority (ESMA) has published on the 9th of January 2019 its advice on Initial Coin Offerings (“ICO”) and Crypto-Assets. This advice highlights a number of issues and gaps in the existing EU regulatory framework and provides insight to the EU policymakers when considering how the regulatory framework can be developed … More Are platforms trading crypto-assets subject to MiFID II/MiFIR?